可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Inoue S ,Murakami Y,Sano K,et al. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation[J]. J Card Fail ,2000 ,6(2) :92-96.
[2] Ohta Y, Shimada T, Yoshitomi H, et al. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation [J]. Can J Cardiol, 2001,17(4): 415-420.
[3] Wilkins MR, Redondo J, Brown LA. The natriuretic peptide family[J]. Lancet, 1997, 349(9061):1307-1310.
[4] Fatkin D,Kelly RP,Feneley MP.Relation between left atrial appendage blood flow velocity,spontaneous echocardiographic contrast and thromboembolic risk in vivo[J]. J Am Coll Cardiol,1994,23(4):961-969.
[5] Shimizu H, Murakami Y, Inoue S,et al. High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation[J] . Stroke,2002 ,33(4):1005-1010.
[6] Raitt MH, Volgman AS, Zoble RG, et al. Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Followup Investigation of Rhythm Management (AFFIRM) study[J]. Am Heart J, 2006,151(2):390-396.
[7] BeckdaSilva L, de Bold A, Fraser M,et al. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm [J]. Can J Cardiol,2004 ,20(12):1245-1248.
[8] Lellouche N, Berthier R, MekontsoDessap A, et al. Usefulness of plasma Btype natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion [J]. Am J Cardiol,2005,95(11):1380-1382.